{"organizations": [], "uuid": "dd85dd1a1326091434e89f5cb36dd2092f3e3804", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/3", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/29/globe-newswire-unity-biotechnology-inc-to-announce-first-quarter-2018-financial-results.html", "country": "US", "domain_rank": 767, "title": "UNITY Biotechnology, Inc. to Announce First 2018 Financial", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-05-30T00:05:00.000+03:00", "replies_count": 0, "uuid": "dd85dd1a1326091434e89f5cb36dd2092f3e3804"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/29/globe-newswire-unity-biotechnology-inc-to-announce-first-quarter-2018-financial-results.html", "ord_in_thread": 0, "title": "UNITY Biotechnology, Inc. to Announce First 2018 Financial", "locations": [], "entities": {"persons": [{"name": "bob goeltz", "sentiment": "none"}], "locations": [{"name": "san francisco", "sentiment": "none"}], "organizations": [{"name": "unity biotechnology, inc.", "sentiment": "neutral"}, {"name": "investors unity biotechnology, inc", "sentiment": "none"}, {"name": "unity biotechnology unity biotechnology", "sentiment": "none"}, {"name": "unity biotechnology, inc", "sentiment": "none"}, {"name": "media canale communications jason spark", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, plans to report results for the first quarter ended March 31, 2018, on Thursday, June 7, 2018, after NASDAQ market close.\nUNITY will not conduct a conference call in conjunction with the financial results press release.\nAbout UNITY Biotechnology\nUNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter .\nInvestors UNITY Biotechnology, Inc. Bob Goeltz Chief Financial Officer 1-650-525-4980 bob.goeltz@unitybiotechnology.com Media Canale Communications Jason Spark 1-619-849-6005 jason@canalecomm.com\nSource:Unity Biotechnology, Inc.", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/4a121eed-5811-436f-a241-7b78803ced85", "https://www.globenewswire.com/Tracker?data=Q71Ewp6ES14LyLG0zZYPaQ-C8PzEQ5HDVnBc1YPzdfjjBLZRkfwYyElN_NQ5ajMtt47QfMRs-02cwRjr62w_OPwQ9yQGLrKByjptGIja9odnhIlukH6HJI2jXyLYumNk", "https://www.globenewswire.com/Tracker?data=xI-bRUzUNF8cNSkE4aLn-BGHjDAcKzt4qWGEwUIu1WWwccF8uqcHvqERh_aGjBsUFxNKxoFjoDGSSk9KE_Hqrw=="], "published": "2018-05-30T00:05:00.000+03:00", "crawled": "2018-05-30T00:59:45.018+03:00", "highlightTitle": ""}